Avatar for Khonsu Therapeutics

Developing therapeutic proteins for autoimmune & inflammatory indications

CEO of Khonsu Therapeutics. BSc Neuroscience, MSc Molecular Cell Biology with Bioinnovation, UCC.
Valuation

$1,200,000

Funded over

1 round

Latest round (Apr 2017)

Seed

Khonsu Therapeutics hasn't added any jobs yet

Get notified when Khonsu Therapeutics posts new jobs.

See similar jobs